MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'centocor'. Sat, 03 Sep 2011 02:27:46 +0100 http://www.medworm.com/index.php?rid=4512611&cid=t_100573_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FCMkq7oeoOAY%2F A US appeals court has reversed a two-year-old jury verdict that found Abbott Labs had to pay $1.67 billion to Johnson & Johnson for infringing a patent on the Remicade arthritis treatment. The spat began when J&J’s Centocor Ortho Biotech unit and New York University filed a lawsuit in 2007, alleging Abbott’s rival Humira med infringed a patent relating to antibodies for treating rheumatoid arthritis. The appeals court, however, decided the Centocor patent was invalid and lacked an adequate written description. The patent “at best, describes a plan for making fully-human antibodies and then identifying those that satisfy the claim limitation,” the court wrote. “But a ‘mere wish or plan’ for obtaining the claimed invention is not sufficie... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4512611 Wed, 23 Feb 2011 17:39:28 +0100 4512611 http://www.medworm.com/index.php?rid=4225652&cid=t_100573_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F12%2Fare-you-serious-tm-good-example-of-why.html Many pharma marketing experts wonder why pharmaceutical marketers spend approximately 70% of their DTC advertising budgets on expensive TV advertising when they might get better bang for their bucks advertising through other channels such as the Internet. Whether or not you agree with that, there's one indisputable factor about TV advertising to consider: the opportunity for brand managers to play at being directors, mingle with the stars, and even to have a "cameo" part in the production.A good example of that is a disease awareness campaign called Are You Serious?TM, launched by Johnson & Johnson's wholly-owned Centocor Ortho Biotech division. This was described in a JNJBTW Blog guest post (here) by Craig Stoltz, Director, Product Communications, Immunology, Centocor Ortho Biotech In... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=4225652 Thu, 02 Dec 2010 12:46:00 +0100 4225652 http://www.medworm.com/index.php?rid=3943024&cid=t_100573_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FkB25Mn-96Xo%2F As a widely anticipated arbitration hearing nears, Johnson & Johnson is demanding unspecified amount of damages in addition to ending a partnership to sell the Remicade and Simponi rheumatoid arthritis treatments, according to a Merck filing with the US Securities and Exchange Commission. At issue are rights to Remicade, which generated $5.5 billion in sales last year, and the newer Simponi follow-up. After Merck bought Schering-Plough, with which J&J had a co-marketing agreement, J&J claimed the takeover canceled their deal, citing a change-of-control provision. J&J subsequently filed for arbitration, which should last 12 business days with a ruling 20 days later, according to Merck. For its part, Merck claimed its takeover was really a reverse merger that was designe... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3943024 Tue, 07 Sep 2010 15:34:26 +0100 3943024 http://www.medworm.com/index.php?rid=3862185&cid=t_100573_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F08%2Fis-phil-mickelson-shilling-for-enbrel.html The golf world was stunned by Tiger Woods' recent poor performance. Another bit of "stunning" news hit the golf world yesterday when the #2 ranked duffer Phil Mickelson announced that he suffers from Psoriatic Arthritis and is being treated with Enbrel. See "Phil Mickelson Arthritis: Will Play At PGA Whistling Straights". The New York Times also ran a story: "Immune Disorder Could Be an Enduring Test for Mickelson".Both these articles mentioned that he was being treated with Enbrel, a drug jointly marketed by AMGEN & PFIZER. The first article I cited includes the subtitle "PGA Championship 2010, Whistling Straits: Phil Mickelson Has Psoriatic Arthritis - Uses Enbrel To Help Manage Condition" and includes this quote from Phil: "I have no aches and pains. My back feels great. I feel stro... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=3862185 Thu, 12 Aug 2010 12:54:00 +0100 3862185 http://www.medworm.com/index.php?rid=3740826&cid=t_100573_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FgGRcWHGyFM0%2F The healthcare giant joins a growing list of drugmakers that are disclosing info about their financial ties to physicians. The move comes after passage of the health care reform bill, which includes a provision known as Physician Payments Sunshine that requires drugmakers each year to record - starting 2012 - all gifts and payments to docs and teaching hospitals. Posting begins in 2013. The J&J list, however, offers both good news and bad news. The good news? J&J is disclosing payments. The bad news? Since J&J runs what are effectively different operating units, there are separate lists for separate units - which makes it difficult to get the bigger picture. The J&J units that have posted their first quarterly reports are Ortho-McNeil-Janssen, Centocor Ortho Biotech and... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3740826 Fri, 09 Jul 2010 12:24:48 +0100 3740826 http://www.medworm.com/index.php?rid=3153624&cid=t_100573_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F01%2Fgsk-please-invite-me-to-sundance-panel.html According to the New York Times, "GlaxoSmithKline is getting into the movie business, pursuing an unusual and most likely controversial strategy to increase interest in a weight-loss drug." That drug, of course, is alli. "Glaxo, the pharmaceutical giant behind Alli, an over-the-counter weight-loss product, has decided that a good way to educate Americans about obesity — and increase sales of Alli — is to finance a “hard-hitting” documentary about eating" (see "Alli Marketer (GSK) To Produce Documentary Film on Eating").Rachel Ferdinando, a Glaxo marketing executive, summarized the film as “the ‘Inconvenient Truth’ of mindless eating,” with the story taking a “behind-closed-doors, fly-on-the-wall” approach that highlights unhealthy relationships people have with food.Fat... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=3153624 Thu, 07 Jan 2010 18:06:00 +0100 3153624 http://www.medworm.com/index.php?rid=2326616&cid=t_100573_136_f&fid=37846&url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F04%2F07%2Fcnto-328-shows-promise-for-ovarian-cancer-in-small-clinical-trial-say-uk-scientists%2F British scientists have developed and clinically tested a drug that could prolong the lives of ovarian cancer patients. A clinical trial of the drug, codenamed CNTO328, has been carried out at the Centre for Experimental Cancer Medicine, which is part of Barts and the London School of Medicine and Dentistry. … The drug is an [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=2326616 Sun, 12 Apr 2009 03:04:22 +0100 2326616 http://www.medworm.com/index.php?rid=1955259&cid=t_100573_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F11%2Ffyi-centocor-launches-new-web-site-to.html Click on image to enlarge (or visit the web site).Here's the press release:Centocor, Inc. announced today the launch of MEDVERSATION(TM) (http://www.medversation.com), an extensive web-based resource designed to facilitate more-informed conversations between U.S. physicians and their patients about the efficacy and safety of REMICADE(R) (infliximab). This interactive web application, in development for the past threeyears and the first in its therapeutic class, provides physicians generalinformation about the progression of certain inflammatory diseases. Inaddition, physicians can access detailed summaries of REMICADE clinicaldata and interactive tools to manage and customize information fordiscussions with patients. "We recognize that health care conversations have become increasinglycomp... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=1955259 Wed, 12 Nov 2008 22:24:00 +0100 1955259 http://www.medworm.com/index.php?rid=1526779&cid=t_100573_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F314556188%2F Nice to see you again. ‘Tis the middle of the week and that can mean only one thing - meetings, projects and deadlines coming at you. And the Blackberry keeps buzzing, too. Never fear, Pharmalot is here…with a few items to help you cope. So grab your morning cup of whatever and dig in… UK Health Service To Get 5 Percent Discount (The Financial Times) Roche Pays Up To $774M For Experimental Cancer Med (Bloomberg News) FDA Panel Approves J&J Psoriasis Drug (Yahoo/Reuters) Alabama Says Drugmakers Cheated Medicaid (Associated Press) (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1526779 Wed, 18 Jun 2008 11:40:43 +0100 1526779 http://www.medworm.com/index.php?rid=1516780&cid=t_100573_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F311261726%2F An experimental drug from the Johnson & Johnson unit appears effective, but FDA medical reviewers believe the biologic could slightly increase cancer risks. The agency reviewers indicate that ustekinumab showed positive results in two comprehensive studies, but may require labeling to warn doctors of possible carcinogenic risks. “Long-term use of ustekinumab may lead to increased risk of tumor development in psoriasis patients,” they wrote. Here is the FDA briefing document. Centocor didn’t assess the risks in its application, and the FDA reviewers wrote that studies in mice suggest the injectable drug could encourage tumor growth. The agency said it would recommend the info is included in any labeling if the med is approved. Here is the Centocor briefing document. ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1516780 Fri, 13 Jun 2008 16:39:26 +0100 1516780 http://www.medworm.com/index.php?rid=1409906&cid=t_100573_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F280778914%2F The healthcare giant yesterday notified employees it will consolidate the sales and marketing operations of two subsidiaries, Ortho Biotech and Centocor, leading to roughly 400 job cuts nationwide, The Star-Ledger of New Jersey reports. The move is a response to the declining sales of its Procrit anemia med, a spokesman tells the paper. Procrit scrips fell sharply last year after the FDA issued new safety warnings, which were also placed on anemia meds sold by Amgen. More recently, an FDA panel recommended that current use should be restricted over concerns the drugs can increase the risk of tumor growth and death. “It is important that we take these significant and difficult steps in our business to free up resources that can be redeployed to opportunities that will make the greate... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1409906 Wed, 30 Apr 2008 13:09:16 +0100 1409906 http://www.medworm.com/index.php?rid=1297781&cid=t_100573_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F03%2Fcentocor-let-thy-employees-speak.html Melissa Katz and Michael Parks of Centocor are getting a lot of feedback about their new corporate blog, CNTO411.And they have responded -- somewhat -- to my suggestion that they allow Centocor's employees to have a voice on the blog (see "Employee Blogging and Other Comments worth Responding to...").I'm happy that my comments have made the grade and this post is designed to press the issue further.So, with apologies to an African American spiritual and the Old Testament of the Bible, specifically Exodus 8:1, I offer this:"And the Blogosphere spake unto Katz and Parks, go unto Centocor's President, and say unto him, thus saith the Blogosphere, Let our employees speak, that they may serve you." When Employees were in Pharma's hand Let your employees speak Oppressed so hard they could not s... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=1297781 Wed, 12 Mar 2008 14:32:00 +0100 1297781 http://www.medworm.com/index.php?rid=1283464&cid=t_100573_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F03%2Fovercoming-pharmas-employee-blogging.html After expressing how bored I am with pharmaceutical company corporate blogs (see "Centocor Blog - No Frying Pan and No Fire!" and "What's Next? I'm Bored!"), and not getting any ideas how to overcome my boredom from readers after 24 hours, I thought I should goose things along with a few out-of-the-box ideas for pharmaceutical company blogs.NOTE: Over half (51.4%, to be exact) of the readers of this blog who have taken the PHARMA MARKETING READER SURVEY want to see more posts about "New Ideas" (see "Who Reads Pharma Marketing Blog?"). That's another reason for this post.If you listen to my podcast conversation with Melissa Katz about Centocor's new CNTO411 blog or read the blog's mission statement, you might pick up something I neglected to mention in previous posts.CNTO411 promises to tal... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=1283464 Thu, 06 Mar 2008 12:33:00 +0100 1283464 http://www.medworm.com/index.php?rid=1280748&cid=t_100573_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F03%2Fcentocor-blog-no-frying-pan-and-no-fire.html Yesterday Melissa Katz and Michael Parks -- the corporate communications brains behind Centocor's new blog CNTO411 (pronounced "Cento 411") -- were my guests on Pharma Marketing Talk, which is my live podcast/chat Internet talk show (you can listen to the audio archive here).Melissa in her follow-up post to CNTO411 likened the experience to being in a frying pan (see "Out of the Frying Pan").Usually, when someone says "out of the frying pan," the next phrase is "into the fire." But, I can assure Melissa that (1) she was never in the frying pan during my interview yesterday, and (2) she hasn't yet seen the fire!Just to clarify: My goal is NEVER to put my podcast guests in a frying pan situation in a live interview situation. I prefer to do that here on this blog!Actually, I do not think Mel... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=1280748 Wed, 05 Mar 2008 12:51:00 +0100 1280748 http://www.medworm.com/index.php?rid=1277879&cid=t_100573_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F03%2Fcentocors-michael-parks-will-join.html Michael Parks, Vice President of Corporate Communications at Centocor, Inc. and the brains behind CNTO411 (see "CNTO411: A New Pharmaceutical Company Blog") plans to be a guest on today's Pharma Marketing Talk podcast about Centocor's new blog.Michael just could not miss the excitement, especially after PharmaGossip's Jack Friday threw down the gauntlet by launching his CentocorGossip counter-blog (see "CentocorGossip: An 'Unofficial' Centocor Blog!").Hope you join us for this LIVE podcast and online CHAT session today a 2 PM Eastern.I will be interviewing Melissa Katz and Michael Parks in a Pharma Marketing Talk podcast on Tuesday, March 4, 2008 at 2 PM. To learn more about this and get instructions for listening in and participating in this podcast, please click here. (Source: Pharma Mar... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=1277879 Tue, 04 Mar 2008 16:22:00 +0100 1277879 http://www.medworm.com/index.php?rid=1270685&cid=t_100573_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F243923176%2F It may not be a trend, but pharma is tip-toeing into the blogosphere. Last year, you may recall, Centocor’s parent created JNJBTW, or Johnson & Johnson By The Way, a now-and-then forum for one of the health care giant’s corporate communications people to chat about various doings and explain why J&J behaves as it does. That was quickly followed by a blog for Glaxo’s Alli, the OTC diet pill which, not surprisingly given the topic, generated more interactive discussion, albeit of the highly restricted form. So now, Centocor is feeling emboldened and rolling out its own version, called CNTO411. Not a great name - CNTO refers to the code Centocor gives drugs under development. And the look is pretty bland. But like JNJBTW, there are hopes and dreams: “We have ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1270685 Sat, 01 Mar 2008 16:35:51 +0100 1270685 http://www.medworm.com/index.php?rid=1186084&cid=t_100573_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F225372838%2F According to a Jan. 3 letter the Johnson & Johnson unit wrote to the New Hampshire attorney general, an undetermined number of computers have gone missing and may be stolen from its Horsham, Pa., headquarters. And one or two contained sensitive personal info belonging to an unspecified number of speakers and consultants who were retained for a ‘National Faculty and Rounds on the Road’ program. (Here’s the letter). Centocor says it was notified of the problem by its IT vendor in early October, 2007, and was provided additional details on Nov. 29th, 2007, although the drugmaker didn’t notify the New Hampshire AG until this month. The letter was written by Michael Schoeck, director of health care compliance at Johnson & Johnson, who also identifies himself as... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1186084 Tue, 29 Jan 2008 17:56:32 +0100 1186084 http://www.medworm.com/index.php?rid=629147&cid=t_100573_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F05%2Finnerstate-correction-and-further.html This morning, I posted an item about Centocor's documentary INNERSTATE and reported that SEIU Local 32BJ filed a lawsuit against J&J claiming that the company used pricing and marketing practices that lead to excessive reimbursements by Medicare, private insurers, and patients. (see "The Innerstate DVD. Is TV Next?"). I also implied that Centocor "hid" this fact and referred to a Local 32BJ protest at a screening of INNERSTATE as merely a labor issue.I'd like to make some corrections and also add a bit to the story.First, a spokesperson for the union wrote me an email and clarified who initated the law suit:"I write to correct today's entry, which says SEIU Local 32BJ filed a lawsuit against J&J. The plantiffs in the case include the federal government, various states, and other entities, ... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=629147 Mon, 21 May 2007 19:52:00 +0100 629147 http://www.medworm.com/index.php?rid=629148&cid=t_100573_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F05%2Finnerstate-dvd-is-tv-next.html NOTE: Please see the follow-up post, "Innerstate: A Correction and Further Criticisms."Depending upon how well a Hollywood movie does at the box office, it usually takes six months or more before the DVD version is released and maybe a year before you can see it on paid TV channels like HBO.By that standard, Centocor's 58-minute disease awareness documentary INNERSTATE must not be doing too well in theaters: less than three months after the movie debuted in New York City, the INNERSTATE DVD arrived in my mailbox. I had signed up to attend a live presentation of the movie at the King of Prussia Mall in Pennsylvania, but decided not to go. After all, I already had a private screening (see "Innerstate Private Screening: Philadelphia Style").INNERSTATE is about patients suffering from psoriasi... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=629148 Mon, 21 May 2007 10:52:00 +0100 629148 http://www.medworm.com/index.php?rid=508524&cid=t_100573_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F105100180%2Fremicade_recommended_for_appro.html Co-developed by Centocor, Inc. and Schering-Plough Corporation (NYSE: SGP), REMICADE® (infliximab) was first approved in the U.S. ( by the USFDA) in 1998 as treatment U.S. for adult Crohn's disease (CD) and later, in 2005, for adult ulcerative colitis. REMICADE® is a monoclonal antibody that specifically targets TNF-alpha, which has been shown to play a role in Crohn's disease (CD), rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), ulcerative colitis (UC) and psoriasis (PsO). REMICADE® is the global market leader among anti-tumor necrosis factor alpha (TNF-alpha) therapies and the only agent approved for the treatment of both RA and CD in North America, the EU and Japan.The USFDA approval of REMICADE® in May 2006 for pediatric patien... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=508524 Thu, 29 Mar 2007 08:12:58 +0100 508524 http://www.medworm.com/index.php?rid=507017&cid=t_100573_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F03%2Fspend-spend-spend-before-end-end-end.html (Source: Pharma Marketing Blog) Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=507017 Wed, 28 Mar 2007 11:49:00 +0100 507017 http://www.medworm.com/index.php?rid=479354&cid=t_100573_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F03%2Finnerstate-private-screening.html (Source: Pharma Marketing Blog) Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=479354 Fri, 09 Mar 2007 13:34:00 +0100 479354 http://www.medworm.com/index.php?rid=469306&cid=t_100573_87_f&fid=34765&url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2007%2F02%2Fghost-filming-biotech-commissions.html A while back, we posted about how a pharmaceutical industry group sponsored the writing of a novel that would support the group's negative point of view about reimportation of drugs from other countries. This seemed at the time to be an audacious example of stealth marketing in health care.Now, one biotechnology company has sponsored the making of a "documentary" movie, just released in theaters, that just happens to underline the suffering that having particular diseases entails, diseases that are now remarkably treatable by drugs that include the company's product. Per the Philadelphia Inquirer,Pharmaceutical promotion is going undercover to a theater near you.Starting next month, moviegoers in select cities will be able to see the heart-wrenching real stories of three people suffering f... Health Care Renewal blogs http://www.medworm.com/rss/comments.php?id=469306 Mon, 26 Feb 2007 20:20:00 +0100 469306